Details for Patent: 9,907,780

Which drugs does patent 9,907,780 protect, and when does it expire?

Patent 9,907,780 protects SILENOR and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 9,907,780

Title:	Low-dose doxepin formulations and methods of making and using the same
Abstract:	The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
Inventor(s):	Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
Assignee:	Currax Pharmaceuticals LLC
Application Number:	US15/394,912
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,907,780
Patent Claim Types: see list of patent claims	Composition; Formulation;

Drugs Protected by US Patent 9,907,780

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Currax	SILENOR	doxepin hydrochloride	TABLET;ORAL	022036-001	Mar 17, 2010	AB	RX	Yes	No			Y
Currax	SILENOR	doxepin hydrochloride	TABLET;ORAL	022036-002	Mar 17, 2010	AB	RX	Yes	Yes			Y

International Family Members for US Patent 9,907,780

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2721133
European Patent Office	2148659
World Intellectual Property Organization (WIPO)	2008128115